All materials contained on this site are protected by Korean copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior consent of the JoongAng Ilbo | Tel: 1577-0510
JoongAng Ilbo Co., Ltd. | Address: 48-6 Sangamsan-ro, Mapo-gu, Seoul, Republic of Korea
Business registration number: 110-81-00999 | CEO & Publisher: Park Chang-hee | Executive Editor: Choi Ji-young
Mail order business report number: 2020-Seoul Mapo-3838 | Online newspaper registration No: 서울,아55177
Date of Registration: 2023. 11. 21 | Juvenile Protection Manager: Park Hyunyoung
![Yuhan Corporation CEO Cho Wook-je speaks during a press conference held in western Seoul on Friday. [YONHAP]](https://image.koreajoongangdaily.com/12466129.jpg?imageId=12466129&width=240&height=184&format=webp&format=jpg)
![Yuhan Corporation's lung cancer drug Leclaza [YUHAN]](https://image.koreajoongangdaily.com/12346596.jpg?imageId=12346596&width=240&height=184&format=webp&format=jpg)
![Lotte Biologics CEO Richard Lee speaks during the 42nd J.P. Morgan Healthcare Conference on Tuesday at the Marriott Marquis hotel dedicated to the Asia-Pacific and Latin America regions' biotech and pharmaceutical companies. [LOTTE BIOLOGICS]](https://image.koreajoongangdaily.com/11576726.jpg?imageId=11576726&width=240&height=184&format=webp&format=jpg)
![The annual J.P. Morgan Healthcare Conference will be held in San Francisco from Jan. 8 to 11, with six Korean companies set to deliver presentations at the event. [SCREEN CAPTURE]](https://image.koreajoongangdaily.com/10731702.jpg?imageId=10731702&width=240&height=184&format=webp&format=jpg)